Literature DB >> 21191015

Factors supporting intrathecal humoral responses following viral encephalomyelitis.

Timothy W Phares1, Cristina P Marques, Stephen A Stohlman, David R Hinton, Cornelia C Bergmann.   

Abstract

Central nervous system (CNS) infections and autoimmune inflammatory disorders are often associated with retention of antibody-secreting cells (ASC). Although beneficial or detrimental contributions of ASC to CNS diseases remain to be defined, virus-specific ASC are crucial in controlling persistent CNS infection following coronavirus-induced encephalomyelitis. This report characterizes expression kinetics of factors associated with ASC homing, differentiation, and survival in the spinal cord, the prominent site of coronavirus persistence. Infection induced a vast, gamma interferon (IFN-γ)-dependent, prolonged increase in chemokine (C-X-C motif) ligand 9 (CXCL9), CXCL10, and CXCL11 mRNA, supporting a role for chemokine (C-X-C motif) receptor 3 (CXCR3)-mediated ASC recruitment. Similarly, CD4 T cell-secreted interleukin-21, a critical regulator of both peripheral activated B cells and CD8 T cells, was sustained during viral persistence. The ASC survival factors B cell-activating factor of the tumor necrosis factor (TNF) family (BAFF) and a proliferating-inducing ligand (APRIL) were also significantly elevated in the infected CNS, albeit delayed relative to the chemokines. Unlike IFN-γ-dependent BAFF upregulation, APRIL induction was IFN-γ independent. Moreover, both APRIL and BAFF were predominantly localized to astrocytes. Last, the expression kinetics of the APRIL and BAFF receptors coincided with CNS accumulation of ASC. Therefore, the factors associated with ASC migration, differentiation, and survival are all induced during acute viral encephalomyelitis, prior to ASC accumulation in the CNS. Importantly, the CNS expression kinetics implicate rapid establishment, and subsequent maintenance, of an environment capable of supporting differentiation and survival of protective antiviral ASC, recruited as plasmablasts from lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191015      PMCID: PMC3067923          DOI: 10.1128/JVI.02260-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis.

Authors:  Shuen-Ing Tschen; Cornelia C Bergmann; Chandran Ramakrishna; Shawn Morales; Roscoe Atkinson; Stephen A Stohlman
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

2.  Virus titres and persistently raised white cell counts in cerebrospinal fluid in mice after peripheral infection with demyelinating Semliki Forest virus.

Authors:  L M Parsons; H E Webb
Journal:  Neuropathol Appl Neurobiol       Date:  1982 Sep-Oct       Impact factor: 8.090

3.  Immunoglobulins in the cerebrospinal fluid: changes during acute viral encephalitis in mice.

Authors:  D E Griffin
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

4.  Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.

Authors:  Roberta Magliozzi; Sandra Columba-Cabezas; Barbara Serafini; Francesca Aloisi
Journal:  J Neuroimmunol       Date:  2004-03       Impact factor: 3.478

5.  Blood brain barrier disturbance and immunoglobulin G levels in the cerebrospinal fluid of the mouse following peripheral infection with the demyelinating strain of Semliki Forest virus.

Authors:  L M Parsons; H E Webb
Journal:  J Neurol Sci       Date:  1982-12       Impact factor: 3.181

6.  Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

Authors:  Barbara Serafini; Barbara Rosicarelli; Roberta Magliozzi; Egidio Stigliano; Francesca Aloisi
Journal:  Brain Pathol       Date:  2004-04       Impact factor: 6.508

7.  Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response.

Authors:  Anja E Hauser; Gudrun F Debes; Sergio Arce; Giuliana Cassese; Alf Hamann; Andreas Radbruch; Rudolf A Manz
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

8.  Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

Authors:  Anna Corcione; Simona Casazza; Elisa Ferretti; Debora Giunti; Emanuela Zappia; Angela Pistorio; Claudio Gambini; Giovanni Luigi Mancardi; Antonio Uccelli; Vito Pistoia
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

9.  BAFF is a survival and maturation factor for mouse B cells.

Authors:  Antonius G Rolink; Jürg Tschopp; Pascal Schneider; Fritz Melchers
Journal:  Eur J Immunol       Date:  2002-07       Impact factor: 5.532

10.  B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation.

Authors:  Svetlana Shulga-Morskaya; Max Dobles; Meghan E Walsh; Lai Guan Ng; Fabienne MacKay; Sambasiva P Rao; Susan L Kalled; Martin L Scott
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

View more
  34 in total

1.  CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis.

Authors:  Cristina P Marques; Parul Kapil; David R Hinton; Claudia Hindinger; Stephen L Nutt; Richard M Ransohoff; Timothy W Phares; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

2.  Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis.

Authors:  Timothy W Phares; Stephen A Stohlman; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

3.  CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis.

Authors:  Timothy W Phares; Stephen A Stohlman; Mihyun Hwang; Booki Min; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

4.  Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis.

Authors:  Jeffrey R Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

5.  T helper cell- and CD40-dependent germline IgM prevents chronic virus-induced demyelinating disease.

Authors:  Cristina Gil-Cruz; Christian Perez-Shibayama; Sonja Firner; Ari Waisman; Ingo Bechmann; Volker Thiel; Luisa Cervantes-Barragan; Burkhard Ludewig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

6.  Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis.

Authors:  Victoria K Baxter; Diane E Griffin
Journal:  J Gen Virol       Date:  2016-09-22       Impact factor: 3.891

7.  Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis.

Authors:  Talibah U Metcalf; Victoria K Baxter; Voraphoj Nilaratanakul; Diane E Griffin
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 8.  The Role of BAFF System Molecules in Host Response to Pathogens.

Authors:  Jiro Sakai; Mustafa Akkoyunlu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

9.  Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages.

Authors:  Niranjan B Butchi; David R Hinton; Stephen A Stohlman; Parul Kapil; Volker Fensterl; Ganes C Sen; Cornelia C Bergmann
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

10.  Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis.

Authors:  Timothy W Phares; Krista D DiSano; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.